Shionogi Smile Heart Co., Ltd.
Basic information
- Head office
- 3-2-1 Futabacho, Toyonaka, Osaka 561-0825, Japan
- Chief executive
- Hiroyuki Tanaka
- Capital
- 20,000,000 JPY
- Employees (non-consolidated)
- Employees (consolidated)
- 55 people
- Start date
- 2018-04-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| Gloridge | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| V:DRIVE | ||||||||
| Verizon社 | ||||||||
| Asahi Group Japan subsidiary, Asahi Beverage Co., Ltd. | ||||||||
| シオノギキャリア開発センター株式会社 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| 全国食支援活動協力会 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
Network
History
Saburo Shiono, who learned the drugstore business from his father, Yoshie, founded the drugstore 'Shiono Saburo Store' at 3-12 Doshomachi, Osaka, on his 24th birthday, March 17, 1878.![]()
Initially dealing mainly with Kampo medicines, in 1886, eight years after founding, Western medicine began to be imported and sold as Western medicine became widespread.![]()
With the graduation of Saburo's second son, Chojuro, from the Department of Pharmacology at Tokyo Imperial University, SHIONOGI began full-scale pharmaceutical research. During this time, the managing pharmacist of Shiono Saburo Store learned from a pediatrician at Osaka Medical College (now Osaka University School of Medicine) that antacid formulations were written in German medical books. Chojuro started trial manufacturing of these antacids and succeeded in productization. This stomach medicine and antacid 'Antacidin' became the first self-developed new drug by Shiono Saburo Store.![]()
Trust and credibility are said to be essential for management. Since its founding, trust and credibility have been the greatest 'capital' for Shiono Saburo Store. The SHIONOGI symbol is derived from the 'Funda' used to weigh medicines on a balance. The Funda symbolizes 'accuracy,' 'honesty,' and 'trust,' reflecting SHIONOGI's constant pursuit of precision.![]()
After successfully developing 'Antacidin,' Saburo built a pharmaceutical factory called 'Shiono Pharmaceutical Plant' in Nishinari District, Osaka (now Fukushima Ward, Osaka City) to expand into full-scale drug manufacturing. This marked the moment SHIONOGI officially became a pharmaceutical company.![]()
In 1919, a year after the end of World War II, to further develop SHIONOGI, Saburo's eldest son, Shotaro, merged the drugstore and pharmaceutical business, Shiono Saburo Store, managed by him, with the pharmaceutical company, Shiono Pharmaceutical Plant, run by his second son, Chojuro, forming Shiono-Yoshi Commercial Co., Ltd.![]()
Following the end of the war, rapid inflation and soaring prices caused chaos, leading to frozen corporate deposits and the termination of wartime compensation, which nearly bankrupted SHIONOGI and put it in its worst management condition since founding.![]()
In 1948, the company announced the 'Three Major Goals to Overcome the Crisis' (1. Raising all technologies, 2. Thorough goal setting and confirmation, 3. Beautification) and started efforts to improve management.![]()
To unify the pharmaceutical business, the company transferred and delegated the sale of herbal medicines, animal medicines, and pharmaceutical wholesale to other companies. To speed up research and development, a subsidiary was established in the U.S. in 2001, and joint development of new drugs with GlaxoSmithKline in the UK began.![]()
In 2011, the company acquired C&O Pharmaceutical Technology (Holdings) Limited, a Chinese pharmaceutical company.![]()
From April 2014 (Heisei 26), the New Medium-Term Management Plan sets a vision to 'grow as a drug discovery-oriented pharmaceutical company,' establishing ROE (Return on Equity) as one of the management indicators, clarifying the items to be achieved over the past three years, and confirming results and issues annually in a rolling manner, clearly demonstrating efforts toward the management goal for 2020.![]()
News
There is no news.
Public records
National Tax Agency basic information1120901039735
- Trade name
- シオノギスマイルハート株式会社
- Trade name (kana)
- シオノギスマイルハート
- Name in English
- Corporation type
- 301
- Address
- 〒561-0825 大阪府豊中市二葉町3丁目2番1号
- Postal code
- 5610825
- Prefecture code
- 27
- City code
- 203
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2018-04-10
- Update date
- 2018-04-13
- Change date
- 2018-04-10
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 01
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 4026665
METI gBizINFO1120901039735
- Corporate number
- 1120901039735
- Trade name
- シオノギスマイルハート株式会社
- Trade name (kana)
- シオノギスマイルハート
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 大阪府豊中市二葉町3丁目2番1号
- Postal code
- 5610825
- Prefecture
- 大阪府
- Prefecture code
- 27
- City or district
- 豊中市
- City code
- 203
- Street address
- 二葉町3丁目2番1号
- Organisation type
- 301
- Processing type
- 01
- Correction type
- 0
- Status
- Representative
- Capital
- Employees
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2018-04-13
- Key information
- 1120901039735